S. Ellery

Biventricular pacing in heart failure.

V. Paul, D. Fluck, S. Ellery, 2004, Hospital medicine.

The role of cardiac resynchronization therapy in heart failure.

M. Frenneaux, L. Williams, S. Ellery, 2005, Minerva cardioangiologica.

A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital – the SCOAST study

R. Veasey, W. Taggu, N. Patel, 2008, International journal of clinical practice.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

A New Endocardial “Over‐the‐Wire” or Stylet‐Driven Left Ventricular Lead:

B. Merkely, K. Tscheliessnigg, C. Unterberg-Buchwald, 2005, Pacing and clinical electrophysiology : PACE.

Complications of biventricular pacing

V. Paul, S. Ellery, 2004 .

Complications of biventricular pacing q

S. Ellery, V. Paul, 2004 .

Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure

M. Frenneaux, L. Williams, S. Ellery, 2006, Postgraduate Medical Journal.

Predicting mortality and rehospitalization in heart failure patients with Home Monitoring—

S. Sack, V. Paul, O. B. O. E. investigators, 2006, Clinical Research in Cardiology.

A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.

Christophe Leclercq, Arnaud Lazarus, Daniel Gras, 2008, Journal of the American College of Cardiology.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Cardiac resynchronisation therapy: a randomised trial of factory or echocardiographic settings for optimum response.

D. Hildick-Smith, R. James, Lorraine Lee, 2013, Heart, lung & circulation.

Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy

A. Hughes, P. Foley, T. Betts, 2019, JACC. Cardiovascular imaging.

Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function

A. Hughes, J. Lumens, L. Anderson, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Short-Term Hemodynamic Effects of Cardiac Resynchronization Therapy in Patients With Heart Failure, a Narrow QRS Duration, and No Dyssynchrony

Paul Steendijk, P. Steendijk, M. Frenneaux, 2009, Circulation.

NO metabolite flux across the human coronary circulation.

M. Frenneaux, P. James, V. Paul, 2007, Cardiovascular research.